Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Manufacturer

Mylan Pharmaceuticals, Inc.

162 drugs, 404 product strengths, 82 recalls on record.

Drugs Mylan Pharmaceuticals, Inc. makes

Atorvastatin+2.4%Generic · 50 makersPharmacies pay from$0.699 open recallsAlbuterol+0.4%Generic · 42 makersPharmacies pay from$5.543 open recallsAmlodipine-2.6%Generic · 33 makersPharmacies pay from$0.3017 open recallsSertraline+0.8%Generic · 42 makersPharmacies pay from$0.852 open recallsGabapentin+4.5%Generic · 72 makersPharmacies pay from$0.667 open recallsPantoprazole+2.7%Generic · 62 makersPharmacies pay from$1.103 open recallsAlprazolam+1.5%Generic · 26 makersPharmacies pay from$0.684 open recallsMethylphenidate-1.0%Generic · 28 makersPharmacies pay from$3.65Unavailable1 open recallPregabalin+5.4%Generic · 38 makersPharmacies pay from$1.341 open recallEsomeprazole-3.4%Generic · 107 makersPharmacies pay from$3.844 open recallsValacyclovir+3.4%Generic · 36 makersPharmacies pay from$6.87Sildenafil+2.3%Generic · 54 makersPharmacies pay from$1.572 open recallsMetformin+2.2%Generic · 65 makersPharmacies pay from$0.44Being discontinued21 open recallsMetoprolol+1.0%Generic · 65 makersPharmacies pay from$0.48Being discontinued9 open recallsPotassium chloride+1.2%Generic · 60 makersPharmacies pay from$2.51Being discontinued2 open recallsPrednisone+0.3%Generic · 39 makersPharmacies pay from$1.11Citalopram+2.3%Generic · 30 makersPharmacies pay from$0.86Cetirizine-4.2%Generic · 146 makersPharmacies pay from$1.365 open recallsLoratadine+3.5%Generic · 145 makersPharmacies pay from$1.641 open recallAllopurinol-1.1%Generic · 39 makersPharmacies pay from$0.94Being discontinuedSpironolactone-0.1%Generic · 35 makersPharmacies pay from$1.28Being discontinued3 open recallsBuspirone-0.8%Generic · 40 makersPharmacies pay from$0.662 open recallsPropranolol-0.6%Generic · 38 makersPharmacies pay from$1.39UnavailableEstradiol-0.5%Generic · 39 makersPharmacies pay from$1.8617 open recallsClonidine-3.4%Generic · 38 makersPharmacies pay from$0.704 open recallsValsartan-0.3%Generic · 26 makersPharmacies pay from$2.42Being discontinued54 open recallsMirtazapine-1.0%Generic · 31 makersPharmacies pay from$1.87Diltiazem+1.6%Generic · 34 makersPharmacies pay from$1.52Being discontinued9 open recallsLevetiracetam-1.9%Generic · 63 makersPharmacies pay from$1.702 open recallsMethotrexate+3.5%Generic · 28 makersPharmacies pay from$3.50Unavailable1 open recallFenofibrate-10.4%Generic · 42 makersPharmacies pay from$2.192 open recallsChlorthalidone-1.6%Generic · 31 makersPharmacies pay from$2.193 open recallsParoxetine+2.3%Generic · 38 makersPharmacies pay from$1.886 open recallsHydrocortisone-0.5%Generic · 212 makersPharmacies pay from$1.45Being discontinued5 open recallsSumatriptan+3.4%Generic · 39 makersPharmacies pay from$7.60Lansoprazole+1.7%Generic · 57 makersPharmacies pay from$3.131 open recallSucralfate-1.9%Generic · 45 makersPharmacies pay from$5.083 open recallsMesalamine-5.0%Generic · 33 makersPharmacies pay from$14.52Being discontinued1 open recallBudesonide+4.1%Generic · 33 makersPharmacies pay from$15.543 open recallsIpratropium+0.3%Generic · 23 makersPharmacies pay from$8.27Clindamycin+2.3%Generic · 52 makersPharmacies pay from$3.14Unavailable13 open recallsFluconazole-3.2%Generic · 31 makersPharmacies pay from$5.73Tretinoin+0.9%Generic · 26 makersPharmacies pay from$9.273 open recallsLatanoprost-0.2%Generic · 15 makersPharmacies pay from$3.932 open recallsMethylprednisolone-4.0%Generic · 25 makersPharmacies pay from$3.03Unavailable5 open recallsMedroxyprogesterone+0.2%Generic · 23 makersPharmacies pay from$3.45Being discontinued5 open recallsNorethindrone+0.2%Generic · 16 makersPharmacies pay from$0.10Liothyronine+1.6%Generic · 15 makersPharmacies pay from$6.17Ticagrelor-4.0%Generic · 21 makersPharmacies pay from$7.29Colchicine-2.6%Generic · 30 makersPharmacies pay from$3.57Lisdexamfetamine+6.8%Generic · 18 makersPharmacies pay from$74.56Limited availability8 open recallsLoperamide+5.2%Generic · 103 makersPharmacies pay from$1.731 open recallKetorolac+3.5%Generic · 57 makersPharmacies pay from$5.11Unavailable12 open recallsValproate+0.7%Generic · 52 makersPharmacies pay from$1.60Unavailable1 open recallEthinyl estradiol / norethindrone-2.9%Generic · 18 makersPharmacies pay from$0.133 open recallsDoxepin+4.3%Generic · 39 makersPharmacies pay from$2.391 open recallDiazepam-6.2%Generic · 38 makersPharmacies pay from$0.63Haloperidol-5.3%Generic · 33 makersPharmacies pay from$2.65Being discontinued9 open recallsVerapamil+8.8%Generic · 31 makersPharmacies pay from$2.15Being discontinued3 open recallsNitroglycerin+1.9%Generic · 32 makersPharmacies pay from$1.96Being discontinued3 open recallsEthinyl estradiol / levonorgestrel+2.4%Generic · 16 makersPharmacies pay from$0.11Carbidopa / levodopa-3.0%Generic · 26 makersPharmacies pay from$2.21Atenolol+1.3%Generic · 30 makersPharmacies pay from$0.66Voriconazole+8.8%Generic · 30 makersPharmacies pay from$25.005 open recallsPrazosin-0.5%Generic · 28 makersPharmacies pay from$2.49Being discontinued9 open recallsTacrolimus+4.1%Generic · 25 makersPharmacies pay from$3.583 open recallsDoxazosin-3.8%Generic · 26 makersPharmacies pay from$1.744 open recallsPhenytoin-0.8%Generic · 25 makersPharmacies pay from$4.31Buprenorphine / naloxone+8.2%Generic · 22 makersPharmacies pay from$16.17Midodrine-3.9%Generic · 25 makersPharmacies pay from$2.321 open recallCarisoprodol+3.1%Generic · 24 makersPharmacies pay from$2.18Dapsone+4.5%Generic · 23 makersPharmacies pay from$13.62Being discontinued4 open recallsAbiraterone+1.8%Generic · 23 makersPharmacies pay from$23.651 open recallEszopiclone+7.3%Generic · 23 makersPharmacies pay from$2.731 open recallHyoscyamine-5.8%Generic · 21 makersPharmacies pay from$4.30Linezolid+2.3%Generic · 23 makersPharmacies pay from$44.22Cimetidine-1.6%Generic · 19 makersPharmacies pay from$6.131 open recallTelmisartan+9.1%Generic · 20 makersPharmacies pay from$3.29Atropine / diphenoxylate+2.9%Generic · 20 makersPharmacies pay from$4.28Rivastigmine-0.9%Generic · 16 makersPharmacies pay from$4.75Being discontinuedFluorouracil+5.2%Generic · 18 makersPharmacies pay from$25.89Sirolimus-1.4%Generic · 17 makersPharmacies pay from$21.381 open recallCyclosporine-0.1%Generic · 14 makersPharmacies pay from$9.934 open recallsDrospirenone / ethinyl estradiol+5.3%Generic · 11 makersPharmacies pay from$0.16Imatinib+3.2%Generic · 15 makersPharmacies pay from$19.33Dabigatran etexilate+0.7%Generic · 13 makersPharmacies pay from$21.469 open recallsAlbuterol / ipratropium-2.8%Generic · 14 makersPharmacies pay from$6.88Armodafinil+1.7%Generic · 11 makersPharmacies pay from$8.88Metolazone+1.0%Generic · 13 makersPharmacies pay from$6.79Benzoyl peroxide / clindamycin-2.0%Generic · 12 makersPharmacies pay from$18.18Clozapine-6.0%Generic · 9 makersPharmacies pay from$7.00Desogestrel / ethinyl estradiol+1.6%Generic · 8 makersPharmacies pay from$0.141 open recallFentanyl-0.4%Generic · 9 makersPharmacies pay from$87.97Unavailable22 open recallsLevalbuterol+2.8%Generic · 11 makersPharmacies pay from$19.121 open recallMacitentanGeneric · 14 makersNo weekly priceMisoprostol-4.1%Generic · 13 makersPharmacies pay from$13.83Formoterol-15.1%Generic · 12 makersPharmacies pay from$64.901 open recallAbacavir+1.2%Generic · 12 makersPharmacies pay from$16.57Hydrochlorothiazide / valsartan-3.2%Generic · 9 makersPharmacies pay from$3.0216 open recallsExemestane-15.7%Generic · 11 makersPharmacies pay from$18.91Risedronate-14.6%Generic · 8 makersPharmacies pay from$5.88Scopolamine-2.6%Generic · 11 makersPharmacies pay from$50.67Travoprost+3.7%Generic · 11 makersPharmacies pay from$21.76Being discontinuedAcamprosate-0.6%Generic · 11 makersPharmacies pay from$17.581 open recallTamoxifen-0.8%Generic · 10 makersPharmacies pay from$3.96Diclofenac / misoprostol+8.6%Generic · 9 makersPharmacies pay from$23.25Difluprednate-6.3%Generic · 10 makersPharmacies pay from$45.37Ambrisentan-9.8%Generic · 10 makersPharmacies pay from$217Amlodipine / atorvastatin-3.3%Generic · 5 makersPharmacies pay from$23.55Bisoprolol / hydrochlorothiazide-0.6%Generic · 9 makersPharmacies pay from$6.571 open recallPitavastatin+1.5%Generic · 8 makersPharmacies pay from$25.105 open recallsColestipol-0.7%Generic · 9 makersPharmacies pay from$19.60Dexlansoprazole+1.4%Generic · 8 makersPharmacies pay from$110Eletriptan+1.0%Generic · 8 makersPharmacies pay from$47.67Glucagon-12.8%Generic · 8 makersPharmacies pay from$1341 open recallSulfasalazine-0.3%Generic · 9 makersPharmacies pay from$5.95Bromocriptine+1.1%Generic · 8 makersPharmacies pay from$48.811 open recallCabergoline-0.5%Generic · 9 makersPharmacies pay from$38.68Eplerenone+7.6%Generic · 8 makersPharmacies pay from$9.94Ethosuximide+7.7%Generic · 8 makersPharmacies pay from$7.87

Recalls

Class IIOngoingSep 9, 2026Carton label: Mycophenolate Mofetil for injectionFailed Dissolution SpecificationsMylan Pharmaceuticals Inc · D-0830-2026Class IIOngoingSep 9, 2026Prasugrel TabletsFailed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteriaMylan Pharmaceuticals Inc · D-0839-2026Class IIOngoingAug 26, 2026Acamprosate CalciumFailed Dissolution SpecificationsMylan Pharmaceuticals Inc · D-0774-2026Class IIOngoingAug 5, 2026Mycophenolate Mofetil for Injection USPPresence of precipitateMylan Pharmaceuticals Inc · D-0734-2026Class IIOngoingMar 11, 2026AmnesteemFailed Dissolution SpecificationsMylan Pharmaceuticals Inc · D-0399-2026Class IIOngoingMar 26, 2025Prasugrel TabletsFailed Dissolution Specifications - low dissolution resultsMylan Pharmaceuticals Inc · D-0280-2025Class ITerminatedAug 3, 2022Insulin GlargineLabeling: Missing label: Label missing from some prefilled pens.Mylan Pharmaceuticals Inc · D-1292-2022Class ITerminatedMay 4, 2022Insulin GlargineLabeling: Missing label on the vialMylan Pharmaceuticals Inc · D-0845-2022Class IITerminatedApr 27, 2022Rifampin for InjectionFailed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing.Mylan Pharmaceuticals Inc · D-0774-2022Class IITerminatedApr 13, 2022Travoprost Ophthalmic SolutionSubpotent Drug and Failed Impurities/Degradation Specifications: low out-of-specification results obtained for assay and high out-of-specification results for related...Mylan Pharmaceuticals Inc · D-0748-2022Class IITerminatedFeb 2, 2022Proctofoam HCcGMP deficienciesMylan Pharmaceuticals Inc · D-0452-2022Class ITerminatedJan 26, 2022SemgleeLabeling: Missing Label: label missing from some Semglee prefilled pens.Mylan Pharmaceuticals Inc · D-0462-2022Class IIITerminatedOct 28, 2020Candesartan Cilexetil and Hydrochlorothiazide TabletsOut-of-specification organic impurity results obtained during routine stability testing.Mylan Pharmaceuticals Inc. · D-0049-2021Class IIITerminatedApr 1, 2020Tacrolimus CapsulesPresence of foreign tablet/capsule - Potential presence of commingled one Tacrolimus 1 mg capsule in 5 mg bottles.Mylan Pharmaceuticals Inc. · D-1057-2020Class IITerminatedMar 25, 2020Sotalol HCL TabletsPresence of particulate matter. presence of metal particles.Mylan Pharmaceuticals Inc. · D-1031-2020Class IITerminatedJan 29, 2020Nizatidine CapsulesCGMP Deviations: Trace amounts of an impurity, N-nitrosodimethylamine (NDMA) was detected in the API Nizatidine.Mylan Pharmaceuticals Inc. · D-0791-2020Class IITerminatedJan 29, 2020Nizatidine CapsulesCGMP Deviations: Trace amounts of an impurity, N-nitrosodimethylamine (NDMA) was detected in the API Nizatidine.Mylan Pharmaceuticals Inc. · D-0792-2020Class IITerminatedNov 13, 2019Alprazolam TabletsPresence of Foreign SubstanceMylan Pharmaceuticals Inc. · D-0186-2020Class IITerminatedNov 6, 2019Prasugrel Tablets 5 mgFailed Dissolution Specification: Low out of specification dissolution results.Mylan Pharmaceuticals Inc. · D-0155-2020Class IIITerminatedSep 18, 2019Gatifloxacin Ophthalmic Solution 0.5%Failed Impurities/Degradation Specifications:OOS for unknown impurity.Mylan Pharmaceuticals Inc. · D-1848-2019Class IIITerminatedFeb 27, 2019Diltiazem HCl Extended-Release CapsulesFailed Impurities/Degradation Specifications: High out of specification results obtained during routine stability testingMylan Pharmaceuticals Inc. · D-0506-2019Class IITerminatedFeb 13, 2019DymistaDefective Container: Potential for broken glass in the neck area of the glass bottles.Mylan Pharmaceuticals Inc. · D-0424-2019Class IITerminatedFeb 6, 2019Fexofenadine HCl TabletsFailed Impurities/Degradation Specifications: Related compound results obtained during routine stability testing was slightly elevated above specification.Mylan Pharmaceuticals Inc. · D-0428-2019Class IIOngoingDec 19, 2018Amlodipine and Valsartan TabletsCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.Mylan Pharmaceuticals Inc. · D-0311-2019Class IIOngoingDec 19, 2018Amlodipine and Valsartan TabletsCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.Mylan Pharmaceuticals Inc. · D-0312-2019Class IIOngoingDec 19, 2018Valsartan TabletsCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.Mylan Pharmaceuticals Inc. · D-0313-2019Class IIOngoingDec 19, 2018Valsartan TabletsCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.Mylan Pharmaceuticals Inc. · D-0314-2019Class IIOngoingDec 19, 2018Valsartan TabletsCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.Mylan Pharmaceuticals Inc. · D-0315-2019Class IIOngoingDec 19, 2018Valsartan TabletsCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.Mylan Pharmaceuticals Inc. · D-0316-2019Class IIOngoingDec 19, 2018Valsartan and Hydrochlorothiazide TabletsCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.Mylan Pharmaceuticals Inc. · D-0317-2019

About Mylan Pharmaceuticals, Inc.

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.